Critical appraisal of androgen use in hereditary angioedema: A systematic review

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 4, 2015, Pages 281-288.e7

  Riedl, Marc A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b 8899 University Center Lane ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CREATINE KINASE; DANAZOL; LIPID; METHYLTESTOSTERONE; OXYMETHOLONE; PLACEBO; STANOZOLOL; TIBOLONE;

ANDROGEN THERAPY; ANGIONEUROTIC EDEMA; ARTICLE; BILIARY TRACT DISEASE; CHOLELITHIASIS; CHOLESTASIS; CHRONIC DRUG ADMINISTRATION; CLINICAL PRACTICE; CONTROLLED CLINICAL TRIAL (TOPIC); CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FATTY LIVER; HAMARTOMA; HEADACHE; HEMANGIOMA; HEMATURIA; HEMORRHAGIC CYSTITIS; HEPATOMEGALY; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER FUNCTION TEST; LIVER HEMANGIOMA; LIVER INJURY; LIVER NECROSIS; LOW DRUG DOSE; MENSTRUAL IRREGULARITY; MOOD CHANGE; MUSCLE CRAMP; MYALGIA; PORTAL HYPERTENSION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; VIRILIZATION; WEIGHT GAIN; ANGIOEDEMAS, HEREDITARY; ANIMAL; DOSE CALCULATION; DRUG EFFECTS; FEMALE; LIPID METABOLISM; MENSTRUATION DISTURBANCES; OBESITY; RISK ASSESSMENT; TIME; VIRILISM;

ANDROGENS; ANGIOEDEMAS, HEREDITARY; ANIMALS; DANAZOL; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; LIPID METABOLISM; MENSTRUATION DISTURBANCES; OBESITY; RISK ASSESSMENT; STANOZOLOL; TIME FACTORS; VIRILISM;

EID: 84926421779     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2015.01.003     Document Type: Review

References (60)

1. J.A. Bernstein HAE update: epidemiology and burden of disease Allergy Asthma Proc 34 2013 3 6
2. B.L. Zuraw, A. Banerji, and J.A. Bernstein US hereditary angioedema association medical advisory board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency J Allergy Clin Immunol Pract 1 2013 458 467
3. M. Cicardi, W. Aberer, and A. Banerji Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group Allergy 69 2014 602 616
4. B.L. Zuraw Hereditary angioedema N Engl J Med 359 2008 1027 1036
5. K.E. Binkley, and A. Davis III Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema J Allergy Clin Immunol 106 2000 546 550
6. B.L. Zuraw, K. Bork, and K.E. Binkley Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel Allergy Asthma Proc 33 2012 S145 S156
7. D.A. Wilson, K. Bork, and E.P. Shea Economic costs associated with acute attacks and long-term management of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 314 320
8. W.R. Lumry, A.J. Castaldo, M.K. Vernon, M.B. Blaustein, D.A. Wilson, and P.T. Horn The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression Allergy Asthma Proc 31 2010 407 414
9. L. Bouillet, D. Launary, and O. Fain Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life in 193 French patients Ann Allergy Asthma Immunol 111 2013 290 294
10. S. Jolles, P. Williams, and E. Carne A UK audit of hereditary and acquired angioedema Clin Exp Immunol 175 2013 59 67
11. R.G. Gower HAE update: determining optimal patient specific therapy Allergy Asthma Proc 34 2013 7 12
12. R.S. Birjmohun, G. Kees Hovingh, and E.S. Stroes Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema Clin Ther 30 2008 2314 2323
13. J.A. Gelfand, R.J. Sherins, D.W. Alling, and M.M. Frank Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities N Engl J Med 295 1976 1444 1448
14. A.L. Sheffer, D.T. Fearon, and K.F. Austen Methyltestosterone therapy in hereditary angioedema Ann Intern Med 86 1977 306 308
15. A. Agostoni, M. Cicardi, G.C. Martignoni, L. Bergamaschini, and B. Marasini Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema J Allergy Clin Immunol 65 1980 75 79
16. G. Füst, H. Farkas, D. Scuka, L. Varga, and K. Bork Long-term efficacy of danazol treatment in hereditary angioedema Eur J Clin Invest 41 2011 256 262
17. S.W. Hosea, M.L. Santaella, E.J. Brown, M. Berger, K. Katusha, and M.M. Frank Long-term therapy of hereditary angioedema with danazol Ann Intern Med 93 1980 809 812
18. H.W. Ott, V. Mattle, and D. Hadziomerovic Treatment of hereditary angioneurotic oedema (HANE) with tibolone Clin Endocrinol (Oxf) 66 2007 180 184
19. R. Perricone, C. De Carolis, F. Giacomello, R. Giacomelli, G. De Sanctis, and L. Fontana Impaired human ovarian follicular fluid complement function in hereditary angioedema Scand J Immunol 51 2000 104 108
20. F.S. Rosen, and A. Beyler Hereditary angioneurotic edema and its correction with androgen therapy Birth Defects Orig Artic Ser 16 1980 499 507
21. C. Rothbach, R.L. Green, M.I. Levine, and P. Fireman Prophylaxis of attacks of hereditary angioedema Am J Med 66 1979 681 683
22. M.L. Santaella, and A. Martinó Hereditary and acquired angioedema: experience with patients in Puerto Rico P R Health Sci J 23 2004 13 18
23. A.L. Sheffer, D.T. Fearon, and K.F. Austen Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema J Allergy Clin Immunol 64 1979 275 280
24. A.L. Sheffer, D.T. Fearon, and K.F. Austen Clinical and biochemical effects of stanozolol therapy for hereditary angioedema J Allergy Clin Immunol 68 1981 181 187
25. A.L. Sheffer, D.T. Fearon, and K.F. Austen Hereditary angioedema: a decade of management with stanozolol [published correction appears in J Allergy Clin Immunol. 1988;81:1208] J Allergy Clin Immunol 80 1987 855 860
26. D. Solé, P.G. Leser, and C.K. Naspitz Hereditary angioedema type II - a study of two families J Investig Allergol Clin Immunol 2 1992 318 322
27. A. Zanicheli, R. Vacchini, and M. Badini Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients Allergy 66 2011 192 196
28. R. Szégedi, G. Széplaki, and L. Varga Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients Atherosclerosis 198 2008 184 191
29. G. Széplaki, L. Varga, and S. Valentin Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema J Allergy Clin Immunol 115 2005 864 869
30. M. Cicardi, R. Castelli, L.C. Zingale, and A. Agostoni Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients J Allergy Clin Immunol 99 1997 194 196
31. D.E. Sloane, C.W. Lee, and A.L. Sheffer Hereditary angioedema: safety of long-term stanozolol therapy J Allergy Clin Immunol 120 2007 654 658
32. G.L. Andriole, C. Brickman, and E.E. Lack Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema J Urol 1351 1986 44 46
33. K. Bork, A. Bygum, and J. Hardt Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients Ann Allergy Asthma Immunol 100 2008 153 161
34. K. Bork, J. Hardt, K.H. Schicketanz, and N. Ressel Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency Arch Intern Med 163 2003 1229 1235
35. K. Bork, M. Pitton, P. Harten, and P. Koch Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema Lancet 353 1999 1066 1067
36. K. Bork, and V. Schneiders Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema J Hepatol 36 2002 707 709
37. W. Bork, K. Wulff, J. Hardt, G. Witzke, and P. Staubach Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy J Allergy Clin Immunol 124 2009 129 134
38. M. Cicardi, L. Bergamaschini, M. Cugno, E. Hack, G. Agostoni, and A. Agostoni Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience J Allergy Clin Immunol 87 1991 768 773
39. M. Cicardi, L. Bergamaschini, B. Marasini, G. Boccassini, A. Tucci, and A. Agostoni Hereditary angioedema: an appraisal of 104 cases Am J Med Sci 284 1982 2 9
40. M. Cicardi, L. Bergamaschini, and A. Tucci Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives J Allergy Clin Immunol 72 1983 294 298
41. M. Cicardi, and L. Zingale How do we treat patients with hereditary angioedema Transfus Apheresis Sci 29 2003 221 227
42. H. Farkas, I. Czaller, and D. Csuka The effect of long-term danazol prophylaxis on liver function in hereditary angioedema: a longitudinal study Eur J Clin Pharmacol 66 2010 419 426
43. H. Farkas, L. Gyeney, E. Gidófalvy, G. Füst, and L. Varga The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures J Oral Maxillofac Surg 57 1999 404 408
44. H. Farkas, G. Harmat, L. Gyeney, G. Füst, and L. Varga Danazol therapy for hereditary angio-oedema in children Lancet 354 1999 1031 1032
45. H. Farkas, G. Harmat, G. Füst, L. Varga, and B. Visy Clinical management of hereditary angio-oedema in children Pediatr Allergy Immunol 13 2002 153 161
46. N. Hoogerbrugge, H. Jansen, and J.C. Birkenhäger Danazol in the treatment of endometriosis and hereditary angio-oedema J Intern Med 237 1995 603 604
47. M. Pedrosa, T. Caballero, C. Gómez-Traseira, A. Olveira, and C. López-Serrano Usefulness of abdominal ultrasonography in the follow-up of patients with hereditary C1-inhibitor deficiency Ann Allergy Asthma Immunol 102 2009 483 486
48. W. Kreuz, I. Martinez-Saguer, E. Aygören-Pürsün, E. Rusicke, C. Heller, and T. Klingebiel C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis Transfusion 49 2009 1987 1995
49. J.J. Zurlo, and M.M. Frank The long-term safety of danazol in women with hereditary angioedema Fertil Steril 54 1990 64 72
50. A.D. Altman, J. McLaughlin, and R. Schellenberg Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report J Obstet Gynaecol Can 28 2006 27 31
51. D. Crampon, R. Barnoud, and M. Durand Danazol therapy: an unusual aetiology of hepatocellular carcinoma J Hepatol 29 1998 1035 1036
52. P. Helsing, and E.W. Nielsen Hepatocellular focal nodular hyperplasia after danazol treatment for hereditary angio-oedema Acta Derm Venereol 86 2006 272 273
53. M.H. Thoufeeq, J. Ishtiaq, and M. Abuzakouk Danazol-induced hepatocellular carcinoma in a patient with hereditary angioedema J Gastrointest Cancer 43 suppl 1 2012 S280 S282
54. M. Cicardi, K. Bork, and T. Caballero Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group Allergy 67 2012 147 157
55. S. Kalaria, and T. Craig Assessment of hereditary angioedema treatment risks Allergy Asthma Proc 34 2013 519 522
56. S. Betschel, J. Badiou, and K. Binkley Canadian hereditary angioedema guideline Allergy Asthma Clin Immunol 10 2014 50
57. M. Riedl, R.G. Gower, and C.A. Chrvala Current medical management of hereditary angioedema: results from a large survey of US physicians Ann Allergy Asthma Immunol 106 2011 316 322
58. Riedl M, Banerji A, Gower R. Current medical management of hereditary angioedema: follow-up survey of US physicians [published online November 18, 2014]. J Allergy Clin Immunol Pract. http://dx.doi.org/10.1016/j.jaip.2014.08.017.
59. D.M. Lang, W. Aberer, and J.A. Bernstein International consensus on hereditary and acquired angioedema Ann Allergy Asthma Immunol 109 2012 395 402
60. Cinryze (human C1-esterase inhibitor) [prescribing Information] July 2012 ViroPharma Biologics Exton, PA